Celyad Oncology SA
10.5 FTECelyad Oncology reported revenue of 21,000 € for the 2025 financial year (non-consolidated annual accounts filed with the NBB on 10 Jun 2026), with 10.5 full-time equivalents.
The score of Celyad Oncology shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue -98 % Equity -90 % Total assets -88 % Headcount (avg FTE) -84 %
Accounts of the company itself (not consolidated). Consolidated group accounts are also filed: they are in the full file.
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Celyad Oncology's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | 21,000 € | ||||
| Net result | −564,911 € | ||||
| Equity | €2.24m | ||||
| Cash | €1.64m | ||||
| EBITDA | −724,185 € | ||||
| Total assets | €4.03m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 10 Jun 2026
- Year ended 31 Dec 2024filed on 21 May 2025
- Year ended 31 Dec 2023filed on 28 May 2024
- Year ended 31 Dec 2022filed on 05 Jun 2023
- Year ended 31 Dec 2021filed on 24 May 2022
Celyad Oncology's financial analysis
- Solvency55.5%sector median: 57.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Celyad Oncology
Celyad Oncology's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0891.118.115
- VAT number
- BE0891118115
- Peppol
- Registered · 0208:0891118115 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 24 Jul 2007
- Registered office
- 1435 Mont-Saint-Guibert
- Size
- Small · 10.5 FTE
- Latest accounts
- 2025 · filed on 10 Jun 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Celyad Oncology (SA) has been based in Mont-Saint-Guibert since 2007, active in: research and experimental development on biotechnology. For 2025, it reports revenue of 21,000 €, a net loss of 564,911 € and equity of €2.24m. With 10.5 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 55.5%, below the median of its sector (57.9%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Celyad Oncology
Companies in the same business, of comparable size and area, outside its group.
- Novobiom Research and experimental development on natural sciences and engineering Liège · balance sheet €3.92m
- Dendrogenix Research and experimental development on natural sciences and engineering Liège · balance sheet €5.28m
- Inhatarget Therapeutics Research and experimental development on natural sciences and engineering Charleroi · balance sheet €2.16m
- H2WIN Research and experimental development on natural sciences and engineering Nivelles · balance sheet €7.36m
- APIX Biosciences Research and experimental development on natural sciences and engineering Wingene · balance sheet €5.89m
- Protea Biopharma NV Research and experimental development on natural sciences and engineering Asse · balance sheet €1.30m
- Tanai Therapeutics Research and experimental development on natural sciences and engineering Ghent · balance sheet €3.87m
- Aneurotech Research and experimental development on natural sciences and engineering Alken · balance sheet €2.91m
Frequently asked questions about Celyad Oncology
What is the revenue of Celyad Oncology?
According to the 2025 annual accounts filed with the NBB, the revenue of Celyad Oncology amounts to 21,000 €.
What is the VAT number of Celyad Oncology?
In Belgium, the VAT number is the company number prefixed with BE: BE0891118115 for Celyad Oncology, if the company is VAT-registered. Its company number (CBE) is 0891.118.115.
Where is the registered office of Celyad Oncology?
According to the CBE register, the registered office of Celyad Oncology is in 1435 Mont-Saint-Guibert.
What is the equity of Celyad Oncology?
At the close of the 2025 financial year, the equity of Celyad Oncology amounts to 2,239,431 €, a solvency of 55.5% of total assets.
How many people work at Celyad Oncology?
10.5 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Celyad Oncology?
The register lists 14 active mandates at Celyad Oncology. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Celyad Oncology
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →